经口无切口胃底折叠术治疗腹腔镜胃底折叠术后复发症状
这项多中心回顾性队列研究评估了经口无切口胃底折叠术(TIF 2.0)用于腹腔镜Nissen或Toupet胃底折叠术后失败患者的可行性、疗效和安全性。20例患者接受TIFFF,GERD-HRQL评分从24.3±22.9改善至14.75±21.6(p=0.014),食管炎愈合率78%,PPI使用从85%降至55%,酸暴露时间从12%±17.8降至0.8%±1.1(p=0.028)。与外科翻修术倾向评分匹配比较,临床疗效无显著差异,但TIFFF晚期不良事件显著更少。
要点
- TIF 2.0可安全有效治疗腹腔镜胃底折叠术后复发反流,需满足食管裂孔疝≤2 cm等解剖条件
- TIFFF后GERD-HRQL和RSI评分显著改善,酸暴露时间显著下降
- 与外科翻修相比临床疗效无显著差异,但TIFFF晚期不良事件更少
核心结论
- 对于有合适解剖条件和客观证据表明持续或复发反流的症状性患者,内镜下TIF补救治疗是再次腹腔镜手术的安全有效替代方案。
研究设计与样本
- 多中心回顾性队列研究,纳入2017年9月至2020年12月接受TIF 2.0技术(EsophyX Z/Z+)的TIFFF患者20例,由消化内科医生和外科医生操作。
- 纳入标准为:复发性GERD症状、基于pH检测或C/D级食管炎或Barrett食管的病理性反流、食管裂孔疝≤2 cm。
- TIFFF队列还与类似的外科再次手术队列进行倾向评分匹配比较。
主要发现
- 20例患者接受TIFFF(距前次胃底折叠术中位时间4.1年),平均GERD-HRQL评分从24.3±22.9改善至14.75±21.6(p=0.014)。
- 平均反流严重指数(RSI)评分从14.1±14.6改善至9.1±8.0(p=0.046),8/10(80%)患者TIF后RSI正常(<13)。
- 食管炎愈合率78%,PPI使用从85%降至55%,8/20(45%)患者停用PPI。
- 平均酸暴露时间从12%±17.8降至0.8%±1.1(p=0.028),9/9(100%)患者TIF后pH正常化。
- TIFFF与外科翻修在临床疗效结局上无统计学显著差异,但TIFFF晚期不良事件显著更少。
关键数值与推荐
- 纳入标准:复发性GERD症状、病理性反流(pH检测或C/D级食管炎或Barrett食管)、食管裂孔疝≤2 cm。
- 主要结局为TIFFF后GERD健康相关生活质量(GERD-HRQL)改善。
临床怎么用
- 对于腹腔镜胃底折叠术后复发反流、食管裂孔疝≤2 cm且有客观反流证据的患者,可考虑TIF 2.0作为外科翻修的替代方案。
- TIF 2.0可由消化内科医生和外科医生操作,术后需评估GERD-HRQL、RSI、PPI使用及pH监测等指标。
局限性
- 本研究为回顾性队列研究,样本量较小(20例TIFFF患者)。
- 原文摘要未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revision of a failed laparoscopic fundoplication carries higher risk of complication and lower chance of success compared to the original surgery. Transoral incisionless fundoplication (TIF) may be an endoscopic alternative for select GERD patients without need of a moderate/large hiatal hernia repair. The aim of this study was to assess feasibility, efficacy, and safety of TIF 2.0 after failed laparoscopic Nissen or Toupet fundoplication (TIFFF). METHODS: This is a multicenter retrospective cohort study of patients who underwent TIFFF between September 2017 and December 2020 using TIF 2.0 technique (EsophyX Z/Z+) performed by gastroenterologists and surgeons. Patients were included if they had (1) recurrent GERD symptoms, (2) pathologic reflux based upon pH testing or Grade C/D esophagitis or Barrett's esophagus, and (3) hiatal hernia ≤ 2 cm. The primary outcome was improvement in GERD Health-Related Quality of Life (GERD-HRQL) post-TIFFF. The TIFFF cohort was also compared to a similar surgical re-operative cohort using propensity score matching. RESULTS: Twenty patients underwent TIFFF (median 4.1 years after prior fundoplication) and mean GERD-HRQL score improved from 24.3 ± 22.9 to 14.75 ± 21.6 (p = 0.014); mean Reflux Severity Index (RSI) score improved from 14.1 ± 14.6 to 9.1 ± 8.0 (p = 0.046) with 8/10 (80%) of patients with normal RSI (< 13) post-TIF. Esophagitis healed in 78% of patients. PPI use decreased from 85 to 55% with 8/20 (45%) patients off of PPI. Importantly, mean acid exposure time decreased from 12% ± 17.8 to 0.8% ± 1.1 (p = 0.028) with 9/9 (100%) of patients with normalized pH post-TIF. There were no statistically significant differences in clinical efficacy outcomes between TIFFF and surgical revision, but TIFFF had significantly fewer late adverse events. CONCLUSION: Endoscopic rescue with TIF is a safe and efficacious alternative to redo laparoscopic surgery in symptomatic patients with appropriate anatomy and objective evidence of persistent or recurrent reflux.
引用
- Ghosh G, Choi AY, Dbouk M, et al. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication. Surg Endosc. 2023. PMID: 36650353. doi:10.1007/s00464-023-09880-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。